Navigation Links
Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404

Rebecca Skye Dietrich Buchanan Communications +44 (0)20 7466 5000

Brian Korb/Seth Lewis The Trout Group +1 646 378 2900

Antisoma disclaimer Certain matters discussed in this statement are forward looking statements that are subject to a number of risks and uncertainties that could cause actual results to differ materially from results, performance or achievements expressed or implied by such statements. These risks and uncertainties may be associated with product discovery and development, including statements regarding the company's clinical development programmes, the expected timing of clinical trials and regulatory filings. Such statements are based on management's current expectations, but actual results may differ materially.

Details of the second lung cancer study This trial was conducted as an open-label extension to the first, randomised study of AS1404 in lung cancer. As in the randomised study, patients were receiving first-line chemotherapy treatment for stage IIIb or IV non-small cell lung cancer. All patients received 1800 mg/m2 AS1404 in combination with carboplatin and paclitaxel. The trial was conducted at hospitals in Germany and New Zealand.

Background on AS1404 AS1404 (DMXAA) is a small-molecule vascular disrupting agent which targets the blood vessels that nourish tumours. The drug was discovered by Professors Bruce Baguley and William Denny and their teams at the Auckland Cancer Society Research Centre, University of Auckland, New Zealand. It was in-licensed by Antisoma from Cancer Research Ventures Limited (now Cancer Research Technology), the development and commercialisation company of the Cancer Research Campaign (now Cancer Research UK), in August 2001. CRUK had supported two phase I studies in the UK and New Zealand.

Background on Antisoma Based in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acqui
'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Data supporting three Antisoma programmes presented at AACR
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
5. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
8. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
9. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
10. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
11. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Antisoma plc Second lung cancer trial adds positive data
(Date:7/6/2015)... , July 6, 2015 Array BioPharma,s ... showcased this past weekend at the 2015 ESMO ... presentation.  At the meeting, data were shared from ... a 100-patient randomized Phase 2 expansion of that ... an EGFR inhibitor, with or without the addition ...
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/4/2015)... Añadir micro esferas de ... línea para pacientes con cáncer colorrectal metastásico no ... libre de progresión en ese órgano ... (mCRC) que se ha propagado sólo al hígado ... de progresión (PFS) en el hígado desde la ...
Breaking Medicine Technology:Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5
... 7 AT&T* and eCardio Diagnostics, one of ... announced the combination of mobile technology with cardiac ... heart patients. AT&T is providing eCardio with ... for near real-time, remote monitoring of cardiac patients. ...
... CVS Caremark (NYSE: CVS ) announced ... as Chief Operating Officer of its pharmacy benefit ... President, Rx Purchasing, Pricing and Network Relations, will ... mail service pharmacy and specialty pharmacy. ...
Cached Medicine Technology:AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 2AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology 3CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer 2
(Date:7/6/2015)... ... 2015 , ... Longevity, the highest regarded provider of early ... Care to offer on-site health screenings. These ultrasound screenings detect early signs of ... accurate and run about an hour long with same day results. , Early ...
(Date:7/6/2015)... DIEGO, CA (PRWEB) , ... July 06, 2015 , ... ... will deliver the keynote address at the 4th Annual Seedstock Sustainable Agriculture Conference – ... This year’s conference , held at the University of California-San Diego, will explore ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... area, Carlson & Associates has once again teamed up with Family Emergency Shelter ... families to move toward self-sufficiency. FESCO was created especially to provide emergency services ...
(Date:7/6/2015)... ... 06, 2015 , ... In a split second, breaking a bone can cause ... having a fracture through the bone health screenings conducted by American Bone Health trained ... because our residents need this information to remain independent and strong for many more ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School of Public ... support a three-year effort to reduce rates of diabetes and cardiovascular disease in ... with the Morehouse School of Medicine’s Prevention Research Center and the Satcher Health ...
Breaking Medicine News(10 mins):Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2
... now the third most affected country by the AIDS virus, ... South African is HIV positive. If this isn’t enough, the ... it refused a huge consignment of one million AIDS detecting ... ,Earlier last year the South African president Thabo Mbeki ...
... world health organization says, water related illnesses claim up to ... coincide with World Water Day on 22nd of March. The ... much of the suffering is needless. People in the developing ... million people die of diarrhea caused by drinking contaminated water ...
... United States of America has zeroed in on the culprit ... been isolated which is said to be the cause for ... the most widely held explanation for this is growing childhood ... scientists were keen on the role of estrogen, a female ...
... raises many uncomfortable questions and more troubling answers is that ... issue and has kindled a lot of heated arguments for ... suffer the most when it comes to drug testing when ... unsuspecting victims in the name of conducting a study.,A new ...
... America, says that children suffer the most when parents divorce. ... a divorce for the sake of children, instead of doing ... the kids, the authors of the study say.,Dr. Allan Booth ... University Park conducted the exhaustive study over a seventeen-year period ...
... Canadian toddler, aged 13 months from Edmonton, Alberta, wandered into ... snow in sub zero temperatures. She was frozen stiff and ... to the hospital, doctors declared her clinically dead, but lo ... a miraculous recovery. Read on to know more. , The ...
Cached Medicine News:
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Straight shafts with 1 x 2 Elsching style teeth. Wide serrated handle with polished finish....
Straight crisscross serrated tips. Flat handle with holes and polished finish....
Medicine Products: